Morgan Stanley’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$102M Buy
965,747
+204,151
+27% +$21.7M 0.01% 1301
2025
Q1
$94.6M Buy
761,596
+100,601
+15% +$12.5M 0.01% 1288
2024
Q4
$81.4M Sell
660,995
-83,940
-11% -$10.3M 0.01% 1415
2024
Q3
$83M Buy
744,935
+29,319
+4% +$3.27M 0.01% 1394
2024
Q2
$76.4M Sell
715,616
-243,489
-25% -$26M 0.01% 1376
2024
Q1
$115M Sell
959,105
-598,501
-38% -$72.1M 0.01% 1084
2023
Q4
$192M Buy
1,557,606
+741,789
+91% +$91.2M 0.01% 1181
2023
Q3
$106M Buy
815,817
+35,456
+5% +$4.59M 0.01% 1020
2023
Q2
$96.7M Buy
780,361
+42,370
+6% +$5.25M 0.01% 1117
2023
Q1
$108M Buy
737,991
+33,998
+5% +$4.97M 0.01% 1016
2022
Q4
$112M Buy
703,993
+28,383
+4% +$4.52M 0.01% 959
2022
Q3
$90.1M Buy
675,610
+13,955
+2% +$1.86M 0.01% 951
2022
Q2
$103M Buy
661,655
+197,519
+43% +$30.8M 0.01% 897
2022
Q1
$72.3M Sell
464,136
-85,734
-16% -$13.3M 0.01% 1061
2021
Q4
$70.1M Sell
549,870
-98,489
-15% -$12.5M 0.01% 1128
2021
Q3
$84.4M Buy
648,359
+148,000
+30% +$19.3M 0.01% 936
2021
Q2
$88.9M Buy
500,359
+224,068
+81% +$39.8M 0.01% 926
2021
Q1
$45.4M Sell
276,291
-1,032
-0.4% -$170K 0.01% 1235
2020
Q4
$45.8M Buy
277,323
+66,429
+31% +$11M 0.01% 1165
2020
Q3
$30.1M Buy
210,894
+40,558
+24% +$5.78M 0.01% 1192
2020
Q2
$18.8M Sell
170,336
-69,989
-29% -$7.72M ﹤0.01% 1446
2020
Q1
$24M Sell
240,325
-37,443
-13% -$3.73M 0.01% 1155
2019
Q4
$41.5M Sell
277,768
-4,784
-2% -$714K 0.01% 1063
2019
Q3
$36.2M Sell
282,552
-658
-0.2% -$84.3K 0.01% 1059
2019
Q2
$40.4M Buy
283,210
+34,451
+14% +$4.91M 0.01% 965
2019
Q1
$35.6M Sell
248,759
-94,615
-28% -$13.5M 0.01% 1044
2018
Q4
$42.6M Sell
343,374
-13,978
-4% -$1.73M 0.01% 901
2018
Q3
$60.1M Buy
357,352
+1,459
+0.4% +$245K 0.02% 847
2018
Q2
$61.3M Buy
355,893
+83,177
+30% +$14.3M 0.02% 802
2018
Q1
$41.2M Buy
272,716
+31,923
+13% +$4.82M 0.01% 1040
2017
Q4
$32.4M Sell
240,793
-1,927
-0.8% -$259K 0.01% 1270
2017
Q3
$35.5M Sell
242,720
-131,015
-35% -$19.2M 0.01% 1126
2017
Q2
$58.1M Sell
373,735
-7,357
-2% -$1.14M 0.02% 828
2017
Q1
$55.3M Buy
381,092
+3,228
+0.9% +$468K 0.02% 852
2016
Q4
$41.2M Buy
377,864
+60,453
+19% +$6.59M 0.01% 1002
2016
Q3
$38.6M Sell
317,411
-63,290
-17% -$7.69M 0.01% 1004
2016
Q2
$53.8M Buy
380,701
+135,239
+55% +$19.1M 0.02% 761
2016
Q1
$32M Buy
245,462
+25,234
+11% +$3.29M 0.01% 1016
2015
Q4
$31M Sell
220,228
-25,366
-10% -$3.57M 0.01% 1101
2015
Q3
$32.6M Sell
245,594
-114,777
-32% -$15.2M 0.01% 1044
2015
Q2
$63.5M Sell
360,371
-44,433
-11% -$7.82M 0.02% 736
2015
Q1
$69.9M Sell
404,804
-57,498
-12% -$9.94M 0.03% 658
2014
Q4
$75.7M Buy
462,302
+9,179
+2% +$1.5M 0.03% 639
2014
Q3
$72.8M Buy
453,123
+84,991
+23% +$13.6M 0.03% 646
2014
Q2
$54.1M Sell
368,132
-130,760
-26% -$19.2M 0.02% 758
2014
Q1
$69.2M Buy
498,892
+153,093
+44% +$21.2M 0.03% 604
2013
Q4
$43.8M Sell
345,799
-28,629
-8% -$3.62M 0.02% 806
2013
Q3
$34.4M Buy
374,428
+84,685
+29% +$7.79M 0.02% 866
2013
Q2
$19.9M Buy
+289,743
New +$19.9M 0.01% 1178